Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for male hypogonadism are effective and should be personalized.

Certain hormone treatments can improve acne and related conditions in women.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Certain drugs that block specific enzymes can help treat prostate diseases.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Prolactin may be important for skin growth and immune function.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Menopause affects hair and skin; more research needed for treatment.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.